JPRN-UMIN000004747招募中1 期
Phase1 trial of Panitumumab combined with S-1 and irrinotecan in advanced/metastatic colorectal cancer - Phase1 trial of Panitumumab combined with S-1 and irrinotecan in advanced/metastatic colorectal cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Multiple malignancies 2. Serious complications(intestinal paralysis and intestinal obstruction, interstitial pneumonia, pulmonary fibrosis,renal failure, cardiac failure , liver failure) 3.Infection 4.Diarrhea 5. mechanical bowel obstruction 6.Uncontrolable pleural effusion or ascites requiring 7.History of serious drug hypersensitivity 8.Need to treatment with flucytosine, atazanavir sulfate 9.Fresh bleeding of digestive organs 10.Cirrhosis, Icterus 11.Evidence of psychiatric disability interfering with enrollment to clinical trial 12.Need to treatment with heart failure, ischemic heart disease or arrhythmia 13.Uncontrolable diabetes 14.Symptomatic brain metastasis 15.Pregnant or lactating women or women of childbearing potential. 16.Patients judged inappropriate for this study by physicians
研究者
相似试验
进行中（未招募）
不适用
A Phase II Clinical Trial of Panitumumab in Combination with Infusional Oxaliplatin and Oral Capecitabine (XELOX) Chemotherapy as 1st line Therapy in Patients with Colorectal Cancer and Advanced Liver Metastases - NDPreviously untreated Patients with Colorectal Cancer and Advanced Liver Metastases.MedDRA version: 9.1Level: LLTClassification code 10052358Term: Colorectal cancer metastaticEUCTR2007-002007-41-ITAZIENDA OSPEDALIERA ORDINE MAURIZIANO
已完成
4 期
Combination therapy trial of panitumumab(Pmab) with FOLFIRI for inoperable advanced recurrent colorectal cancer first-line chemotherapyadvanced and recurrent colorectal cancerJPRN-UMIN000005196Kyoto Prefectural University of Medicine70
已完成
1 期
Phase I trial of S-1 plus Lapatinib in patients with HER-2 positive metastatic breast cancerbreast cancerJPRN-UMIN000004921Tokai University School of Medicine6
尚未招募
1 期
Phase I/II trial of S-1+Nedaplatin+Cetuximab for recurrent/metastatic head and neck squamous cell carcinomahead and neck squamous cell carcinomaJPRN-UMIN000012074Kyorin University School of Medicine, Department of Otolaryngology30
招募中
2 期
Multicenter phase II trial of panitumumab plus irinotecan and S-1 (PIRIS regimen) in patients treated by oxaliplatin-based chemotherapy with K-RAS wild-type advanced colorectal cancer.Colorectal CancerJPRN-UMIN000004574Showa University Nothern Yokohama Hospital48